State Street’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $826M | Buy |
3,293,778
+41,758
| +1% | +$10.4M | 0.03% | 443 |
|
|
2025
Q4 | $895M | Buy |
3,252,020
+44,109
| +1% | +$12.1M | 0.03% | 421 |
|
|
2025
Q3 | $842M | Sell |
3,207,911
-63,955
| -2% | -$15.5M | 0.03% | 436 |
|
|
2025
Q2 | $716M | Buy |
3,271,866
+68,330
| +2% | +$14.6M | 0.03% | 459 |
|
|
2025
Q1 | $717M | Sell |
3,203,536
-43,177
| -1% | -$11.9M | 0.03% | 444 |
|
|
2024
Q4 | $1.06B | Buy |
3,246,713
+32,265
| +1% | +$10.2M | 0.04% | 359 |
|
|
2024
Q3 | $965M | Buy |
3,214,448
+10,060
| +0.3% | +$3.08M | 0.04% | 381 |
|
|
2024
Q2 | $1.06B | Sell |
3,204,388
-14,592
| -0.5% | -$5.16M | 0.05% | 335 |
|
|
2024
Q1 | $1.27B | Sell |
3,218,980
-52,949
| -2% | -$19.6M | 0.06% | 294 |
|
|
2023
Q4 | $1.15B | Buy |
3,271,929
+53,421
| +2% | +$18.9M | 0.06% | 313 |
|
|
2023
Q3 | $1.21B | Sell |
3,218,508
-50,974
| -2% | -$19.7M | 0.07% | 271 |
|
|
2023
Q2 | $1.25B | Sell |
3,269,482
-20,388
| -0.6% | -$7.28M | 0.07% | 282 |
|
|
2023
Q1 | $1.14B | Sell |
3,289,870
-69,645
| -2% | -$20.3M | 0.06% | 295 |
|
|
2022
Q4 | $791M | Buy |
3,359,515
+28,241
| +0.8% | +$6.69M | 0.05% | 375 |
|
|
2022
Q3 | $820M | Buy |
3,331,274
+7,565
| +0.2% | +$2.3M | 0.05% | 347 |
|
|
2022
Q2 | $1B | Sell |
3,323,709
-70,198
| -2% | -$22.8M | 0.06% | 305 |
|
|
2022
Q1 | $1.39B | Sell |
3,393,907
-61,802
| -2% | -$24.2M | 0.07% | 269 |
|
|
2021
Q4 | $1.62B | Buy |
3,455,709
+54,510
| +2% | +$23.5M | 0.08% | 258 |
|
|
2021
Q3 | $1.44B | Sell |
3,401,199
-9,736
| -0.3% | -$4.1M | 0.08% | 257 |
|
|
2021
Q2 | $1.22B | Buy |
3,410,935
+115,853
| +4% | +$38.3M | 0.06% | 295 |
|
|
2021
Q1 | $928M | Sell |
3,295,082
-52,149
| -2% | -$14.9M | 0.05% | 341 |
|
|
2020
Q4 | $948M | Sell |
3,347,231
-132,955
| -4% | -$37.3M | 0.06% | 310 |
|
|
2020
Q3 | $957M | Buy |
3,480,186
+5,132
| +0.1% | +$1.36M | 0.07% | 281 |
|
|
2020
Q2 | $789M | Buy |
3,475,054
+687,428
| +25% | +$135M | 0.06% | 309 |
|
|
2020
Q1 | $424M | Buy |
2,787,626
+53,552
| +2% | +$8.24M | 0.04% | 413 |
|
|
2019
Q4 | $411M | Buy |
2,734,074
+577,028
| +27% | +$84M | 0.03% | 515 |
|
|
2019
Q3 | $306M | Sell |
2,157,046
-103,991
| -5% | -$14.3M | 0.02% | 561 |
|
|
2019
Q2 | $283M | Sell |
2,261,037
-28,523
| -1% | -$3.37M | 0.02% | 599 |
|
|
2019
Q1 | $252M | Buy |
2,289,560
+155,303
| +7% | +$16.2M | 0.02% | 612 |
|
|
2018
Q4 | $209M | Sell |
2,134,257
-223,457
| -9% | -$24.2M | 0.02% | 616 |
|
|
2018
Q3 | $291M | Buy |
2,357,714
+4,444
| +0.2% | +$498K | 0.02% | 575 |
|
|
2018
Q2 | $234M | Sell |
2,353,270
-46,001
| -2% | -$4.23M | 0.02% | 633 |
|
|
2018
Q1 | $212M | Sell |
2,399,271
-55,776
| -2% | -$5.22M | 0.02% | 668 |
|
|
2017
Q4 | $242M | Buy |
2,455,047
+56,427
| +2% | +$5.53M | 0.02% | 618 |
|
|
2017
Q3 | $231M | Sell |
2,398,620
-112,488
| -4% | -$10.2M | 0.02% | 622 |
|
|
2017
Q2 | $237M | Buy |
2,511,108
+67,937
| +3% | +$6.25M | 0.02% | 610 |
|
|
2017
Q1 | $199M | Sell |
2,443,171
-104,358
| -4% | -$8.73M | 0.02% | 650 |
|
|
2016
Q4 | $216M | Buy |
2,547,529
+46,389
| +2% | +$3.65M | 0.02% | 619 |
|
|
2016
Q3 | $186M | Sell |
2,501,140
-32,760
| -1% | -$2.6M | 0.02% | 645 |
|
|
2016
Q2 | $192M | Sell |
2,533,900
-531,923
| -17% | -$38.7M | 0.02% | 619 |
|
|
2016
Q1 | $213M | Sell |
3,065,823
-216,120
| -7% | -$13M | 0.02% | 588 |
|
|
2015
Q4 | $198M | Buy |
3,281,943
+174,171
| +6% | +$10.5M | 0.02% | 607 |
|
|
2015
Q3 | $168M | Buy |
3,107,772
+697,869
| +29% | +$40.7M | 0.02% | 645 |
|
|
2015
Q2 | $140M | Sell |
2,409,903
-397,809
| -14% | -$22.2M | 0.02% | 735 |
|
|
2015
Q1 | $169M | Sell |
2,807,712
-358,395
| -11% | -$19.1M | 0.02% | 661 |
|
|
2014
Q4 | $169M | Sell |
3,166,107
-42,675
| -1% | -$2.13M | 0.02% | 654 |
|
|
2014
Q3 | $144M | Buy |
3,208,782
+230,628
| +8% | +$9.8M | 0.02% | 692 |
|
|
2014
Q2 | $126M | Buy |
2,978,154
+238,496
| +9% | +$10.2M | 0.01% | 773 |
|
|
2014
Q1 | $121M | Buy |
2,739,658
+1,159,903
| +73% | +$54.6M | 0.01% | 774 |
|
|
2013
Q4 | $77.5M | Sell |
1,579,755
-15,695
| -1% | -$734K | 0.01% | 965 |
|
|
2013
Q3 | $65.7M | Buy |
1,595,450
+19,756
| +1% | +$754K | 0.01% | 1014 |
|
|
2013
Q2 | $55.4M | Buy |
+1,575,694
| New | +$51.9M | 0.01% | 1046 |
|
Other funds holding WST
VCM
VPM
GIM
State Street's WST Position: Q1 2026 in Review
State Street increased its West Pharmaceutical (WST) stake by 1.3% in Q1 2026, buying an estimated $10.4M and bringing the position to 3,293,778 shares worth $826M. The position accounts for 0.03% of the portfolio, ranked #443.
State Street first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.62B in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- State Street held 3,293,778 shares of West Pharmaceutical worth $826M as of Q1 2026.
- State Street bought 41,758 West Pharmaceutical shares in Q1 2026, an estimated $10.4M.
- West Pharmaceutical made up 0.03% of State Street's portfolio in Q1 2026, its #443 holding.
- State Street first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- State Street's West Pharmaceutical position peaked at $1.62B in Q4 2021.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.